BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8835553)

  • 1. The evolution of Raynaud's phenomenon: a longterm prospective study.
    Luggen M; Belhorn L; Evans T; Fitzgerald O; Spencer-Green G
    J Rheumatol; 1995 Dec; 22(12):2226-32. PubMed ID: 8835553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic S; Damjanov NS; Stojanovic RM; Vujasinovic Stupar NZ; Stanisavljevic DM
    Rheumatol Int; 2012 Oct; 32(10):3039-45. PubMed ID: 21901350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of the evolution of Raynaud's phenomenon.
    Fitzgerald O; Hess EV; O'Connor GT; Spencer-Green G
    Am J Med; 1988 Apr; 84(4):718-26. PubMed ID: 3261127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud's phenomenon.
    Farenhorst CA; Roon AM; Gessel AI; Stel AJ; Bootsma H; Armbrust W; Mulder DJ
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):11. PubMed ID: 35135560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.
    Kallenberg CG; Wouda AA; Hoet MH; van Venrooij WJ
    Ann Rheum Dis; 1988 Aug; 47(8):634-41. PubMed ID: 3261966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma.
    ter Borg EJ; Piersma-Wichers G; Smit AJ; Kallenberg CG; Wouda AA
    Semin Arthritis Rheum; 1994 Aug; 24(1):40-7. PubMed ID: 7985036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease.
    Maricq HR; Harper FE; Khan MM; Tan EM; LeRoy EC
    Clin Exp Rheumatol; 1983; 1(3):195-205. PubMed ID: 6335855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image analysis of nail fold capillaries in patients with Raynaud's phenomenon.
    Ohtsuka T; Yamakage A; Tamura T
    Cutis; 1995 Oct; 56(4):215-8. PubMed ID: 8575220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.
    Harper FE; Maricq HR; Turner RE; Lidman RW; Leroy EC
    Am J Med; 1982 Jun; 72(6):883-8. PubMed ID: 7091158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon.
    Meli M; Gitzelmann G; Koppensteiner R; Amann-Vesti BR
    Clin Rheumatol; 2006 Mar; 25(2):153-8. PubMed ID: 15951918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nailfold dermatoscopy in general practice.
    Rennie D
    Aust Fam Physician; 2015; 44(11):809-12. PubMed ID: 26590619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients.
    Joyal F; Choquette D; Roussin A; Levington C; Senécal JL
    Angiology; 1992 Mar; 43(3 Pt 1):203-10. PubMed ID: 1575368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
    Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
    Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.